{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T09:14:24Z","timestamp":1790154864535,"version":"4.0.1"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2017,3,10]],"date-time":"2017-03-10T00:00:00Z","timestamp":1489104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["N01AI85346"],"award-info":[{"award-number":["N01AI85346"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U19AI065683"],"award-info":[{"award-number":["U19AI065683"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","award":["D43TW001589"],"award-info":[{"award-number":["D43TW001589"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000200","name":"United States Agency for International Development","doi-asserted-by":"publisher","award":["W81XWH-06-1-0427"],"award-info":[{"award-number":["W81XWH-06-1-0427"]}],"id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0173294","type":"journal-article","created":{"date-parts":[[2017,3,10]],"date-time":"2017-03-10T18:41:58Z","timestamp":1489171318000},"page":"e0173294","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Strain-specific Plasmodium falciparum growth inhibition among Malian children immunized with a blood-stage malaria vaccine"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3874-581X","authenticated-orcid":true,"given":"Matthew B.","family":"Laurens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bourema","family":"Kouriba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Bergmann-Leitner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelina","family":"Angov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drissa","family":"Coulibaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issa","family":"Diarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Modibo","family":"Daou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amadou","family":"Niangaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Blackwelder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Ripley","family":"Ballou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Vekemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Lanar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheetij","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carter","family":"Diggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine","family":"Soisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Gray","family":"Heppner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ogobara K.","family":"Doumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher V.","family":"Plowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahamadou A.","family":"Thera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,3,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJMoa1008115","article-title":"A field trial to assess a blood-stage malaria vaccine","volume":"365","author":"MA Thera","year":"2011","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"47533","DOI":"10.1074\/jbc.M207145200","article-title":"Serine repeat antigen (SERA5) is predominantly expressed among the SERA multigene family of Plasmodium falciparum, and the acquired antibody titers correlate with serum inhibition of the parasite growth","volume":"277","author":"S Aoki","year":"2002","journal-title":"J Biol Chem"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1128\/IAI.73.6.3677-3685.2005","article-title":"Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malaria","volume":"73","author":"EM Malkin","year":"2005","journal-title":"Infect Immun"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"e2940","DOI":"10.1371\/journal.pone.0002940","article-title":"Phase 1 trial of AMA1-C1\/Alhydrogel plus CPG 7909: an asexual blood-stage vaccine for Plasmodium falciparum malaria","volume":"3","author":"GE Mullen","year":"2008","journal-title":"PLoS ONE"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1128\/CVI.00042-09","article-title":"Anti-apical-membrane-antigen-1 antibody is more effective than anti-42-kilodalton-merozoite-surface-protein-1 antibody in inhibiting plasmodium falciparum growth, as determined by the in vitro growth inhibition assay","volume":"16","author":"K Miura","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1128\/IAI.00960-09","article-title":"In vitro growth-inhibitory activity and malaria risk in a cohort study in Mali","volume":"78","author":"PD Crompton","year":"2010","journal-title":"Infect Immun"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0035-9203(89)90478-1","article-title":"Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infection","volume":"83","author":"K Marsh","year":"1989","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"e3571","DOI":"10.1371\/journal.pone.0003571","article-title":"Acquisition of growth-inhibitory antibodies against blood-stage Plasmodium falciparum","volume":"3","author":"FJ McCallum","year":"2008","journal-title":"PLoS ONE"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1086\/426398","article-title":"Antibodies to the conserved C-terminal domain of the Plasmodium falciparum merozoite surface protein 1 and to the merozoite extract and their relationship with in vitro inhibitory antibodies and protection against clinical malaria in a Senegalese village","volume":"191","author":"R Perraut","year":"2005","journal-title":"J Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/infdis\/jir222","article-title":"Effect of the pre-erythrocytic candidate malaria vaccine RTS,S\/AS01E on blood stage immunity in young children","volume":"204","author":"P Bejon","year":"2011","journal-title":"J Infect Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"12488","DOI":"10.1073\/pnas.0701464104","article-title":"Structural basis of antigenic escape of a malaria vaccine candidate","volume":"104","author":"S Dutta","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref12","first-page":"2ra5","article-title":"Extreme polymorphism in a vaccine antigen and risk of clinical malaria: Implications for vaccine development","author":"SL Takala","year":"2009","journal-title":"Sci Transl Med 1"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/978-1-4939-2815-6_13","article-title":"Miniaturized growth inhibition assay to assess the anti-blood stage activity of antibodies","volume":"1325","author":"EH Duncan","year":"2015","journal-title":"Methods Mol Biol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/infdis\/jis709","article-title":"Molecular basis of allele-specific efficacy of a blood-stage malaria vaccine: vaccine development implications","volume":"207","author":"A Ouattara","year":"2013","journal-title":"J Infect Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1475-2875-7-129","article-title":"Evaluation of immunoglobulin purification methods and their impact on quality and yield of antigen-specific antibodies","volume":"7","author":"ES Bergmann-Leitner","journal-title":"Malar J"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4269\/ajtmh.1999.60.135","article-title":"Differential effect and interaction of monocytes, hyperimmune sera, and immunoglobulin G on the growth of asexual stage Plasmodium falciparum parasites","volume":"60","author":"YP Shi","year":"1999","journal-title":"Am J Trop Med Hyg"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"437","DOI":"10.4269\/ajtmh.2006.75.437","article-title":"Critical evaluation of different methods for measuring the functional activity of antibodies against malaria blood stage antigens","volume":"75","author":"ES Bergmann-Leitner","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1086\/426398","article-title":"Antibodies to the conserved C-terminal domain of the Plasmodium falciparum merozoite surface protein 1 and to the merozoite extract and their relationship with in vitro inhibitory antibodies and protection against clinical malaria in a Senegalese village","volume":"191","author":"R Perraut","year":"2005","journal-title":"J Infect Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e5254","DOI":"10.1371\/journal.pone.0005254","article-title":"Phase 1\/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A","volume":"4","author":"MD Spring","year":"2009","journal-title":"PLoS ONE"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e1465","DOI":"10.1371\/journal.pone.0001465","article-title":"Safety and immunogenicity of an AMA-1 malaria vaccine in Malian adults: results of a phase 1 randomized controlled trial","volume":"3","author":"MA Thera","year":"2008","journal-title":"PLoS ONE"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e3557","DOI":"10.1371\/journal.pone.0003557","article-title":"Antibody-mediated growth inhibition of Plasmodium falciparum: relationship to age and protection from parasitemia in Kenyan children and adults","volume":"3","author":"AE Dent","year":"2008","journal-title":"PLoS ONE"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e3571","DOI":"10.1371\/journal.pone.0003571","article-title":"Acquisition of growth-inhibitory antibodies against blood-stage Plasmodium falciparum","volume":"3","author":"FJ McCallum","year":"2008","journal-title":"PLoS ONE"},{"key":"ref23","first-page":"354","article-title":"Extended safety, immunogenicity and efficacy of WRAIR's AMA1 malaria vaccine (FMP2.1) adjuvanted in GSK biologicals' AS02A in 1\u20136 year old children in Bandiagara, Mali","volume":"85","author":"MA Thera","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/infdis\/jir223","article-title":"Antibodies to Plasmodium falciparum antigens predict a higher risk of malaria but protection from symptoms once parasitemic","volume":"204","author":"B Greenhouse","year":"2011","journal-title":"J Infect Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1182\/blood.V84.5.1594.1594","article-title":"Merozoite surface protein-3: a malaria protein inducing antibodies that promote Plasmodium falciparum killing by cooperation with blood monocytes","volume":"84","author":"C Oeuvray","year":"1994","journal-title":"Blood"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1084\/jem.182.2.409","article-title":"Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages","volume":"182","author":"H Bouharoun-Tayoun","year":"1995","journal-title":"J Exp Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1084\/jem.172.6.1633","article-title":"Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes","volume":"172","author":"H Bouharoun-Tayoun","year":"1990","journal-title":"J Exp Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1128\/IAI.68.5.2617-2620.2000","article-title":"Cytophilic immunoglobulin responses to Plasmodium falciparum glutamate-rich protein are correlated with protection against clinical malaria in Dielmo","volume":"68","author":"C Oeuvray","year":"2000","journal-title":"Senegal. Infect Immun"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1128\/IAI.66.1.11-17.1998","article-title":"The glutamate-rich protein (GLURP) of Plasmodium falciparum is a target for antibody-dependent monocyte-mediated inhibition of parasite growth in vitro","volume":"66","author":"M Theisen","year":"1998","journal-title":"Infect Immun"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"e55571","DOI":"10.1371\/journal.pone.0055571","article-title":"DNA prime\/Adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity","volume":"8","author":"I Chuang","year":"2013","journal-title":"PLoS ONE"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1186\/1475-2875-12-376","article-title":"Ex vivo tetramer staining and cell surface phenotyping for early activation markers CD38 and HLA-DR to enumerate and characterize malaria antigen-specific CD8+ T-cells induced in human volunteers immunized with a Plasmodium falciparum adenovirus-vectored malaria vaccine expressing AMA1","volume":"12","author":"R Schwenk","year":"2013","journal-title":"Malar J"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0173294","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T18:30:02Z","timestamp":1601749802000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0173294"}},"subtitle":[],"editor":[{"given":"Takafumi","family":"Tsuboi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,3,10]]},"references-count":31,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,3,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0173294","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,10]]}}}